Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment

Autor: Sen, S, Ahmad, Y, Dehbi, H-M, Howard, JP, Iglesias, JF, Al-Lamee, R, Petraco, R, Nijjer, S, Bhindi, R, Lehman, S, Walters, D, Sapontis, J, Janssens, L, Vrints, CJ, Khashaba, A, Laine, M, Van Belle, E, Krackhardt, F, Bojara, W, Going, O, Härle, T, Indolfi, C, Niccoli, G, Ribichini, F, Tanaka, N, Yokoi, H, Takashima, H, Kikuta, Y, Erglis, A, Vinhas, H, Silva, PC, Baptista, SB, Alghamdi, A, Hellig, F, Koo, B-K, Nam, C-W, Shin, E-S, Doh, J-H, Brugaletta, S, Alegria-Barrero, E, Meuwissen, M, Piek, JJ, Van Royen, N, Sezer, M, Di Mario, C, Gerber, RT, Malik, IS, Sharp, ASP, Talwar, S, Tang, K, Samady, H, Altman, J, Seto, AH, Singh, J, Jeremias, A, Matsuo, H, Kharbanda, RK, Patel, MR, Serruys, P, Escaned, J, Davies, JE

BACKGROUND: Physicians are not always comfortable deferring treatment of a stenosis in the left anterior descending (LAD) artery because of the perception that there is a high risk of major adverse cardiac events (MACE). The authors describe, using t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::546983d3479731dde9f0215c043c266d
http://hdl.handle.net/11562/992022

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

Autor: Townsend, RR, Mahfoud, F, Kandzari, DE, Kario, K, Pocock, S, Weber, MA, Ewen, S, Tsioufis, K, Tousoulis, D, Sharp, ASP, Watkinson, AF, Schmieder, RE, Schmid, A, Choi, JW, East, C, Walton, A, Hopper, I, Cohen, DL, Wilensky, R, Lee, DP, Ma, A, Devireddy, CM, Lea, JP, Lurz, PC, Fengler, K, Davies, J, Chapman, N, Cohen, SA, DeBruin, V, Fahy, M, Jones, DE, Rothman, M, Böhm, M, SPYRAL HTN-OFF MED trial investigators, COLLABORATORS, Aoki, J, Batson, B, Dangas, G, David, S, Kandzari, D, Patel, M, Patel, K, Singh, J, Weber, T, Weil, J, Zeller, T, Ziada, K, Tanabe, K, Wilkins, R, Contreras, J, Steigerwalt, S, Reedus, D, Hoshide, S, Svetkey, L, Rao, A, Brown, A, Suppan, M, Agdirlioglu, T, Noory, E, Chasen, C

Previous randomised renal denervation studies did not show consistent efficacy in reducing blood pressure. The objective of our study was to evaluate the effect of renal denervation on blood pressure in the absence of antihypertensive medications. SP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::7533660c9f12d3265d24a4e2762a4676

A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot study.

Autor: Sharp ASP; University Hospital of Wales and Cardiff University, Cardiff, UK. Electronic address: drandrewsharp@gmail.com., Kandzari DE; Piedmont Heart Institute, Atlanta, GA, USA., Townsend RR; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kario K; Department of Cardiovascular Medicine, Jichi Medical University of Medicine, Tochigi, Japan., Mahfoud F; Universitatsklinikum des Saarlandes, Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin, Saarland University, Homburg, Germany., Weber MA; SUNY Downstate College of Medicine, New York, NY, USA., Schmieder RE; University Hospital Erlangen, Erlangen, Germany., Tsioufis K; National and Kapodistrian University of Athens Hippocratio Hospital, Athens, Greece., Böhm M; Universitatsklinikum des Saarlandes, Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin, Saarland University, Homburg, Germany., Choi JW; Baylor Research Institute, Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX, USA., Liu M; Medtronic, Santa Rosa, CA, USA., DeBruin V; Medtronic, Santa Rosa, CA, USA., Lee DP; Stanford Hospital and Clinics, Stanford, CA, USA.

Publikováno v: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 Nov; Vol. 68, pp. 30-36. Date of Electronic Publication: 2024 Apr 10.

Standardized Data Elements for Patients With Acute Pulmonary Embolism: A Consensus Report From the Pulmonary Embolism Research Collaborative.

Autor: Rosenfield K; Division of Cardiology, Massachusetts General Hospital, Boston (K.R., J.Y.)., Bowers TR; Division of Cardiovascular Medicine, Beaumont University Hospital, Corewell Health, Royal Oak, MI (T.R.B.)., Barnett CF; Division of Cardiology, University of California, San Francisco (C.F.B.)., Davis GA; University of Kentucky HealthCare, University of Kentucky College of Pharmacy, Lexington (G.A.D.)., Giri J; Cardiovascular Medicine Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia (J.G.)., Horowitz JM; Langone Health, Department of Medicine, Division of Cardiology, New York University, New York (J.M.H.)., Huisman MV; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Netherlands (M.V.H., F.A.K.).; Dutch Thrombosis Network, Leiden, Netherlands (M.V.H., F.A.K.)., Hunt BJ; Department of Hematology, Kings Healthcare Partners, London, United Kingdom (B.J.H.)., Keeling B; Division of Cardiovascular Surgery, Emory University, Atlanta, GA (B.K.)., Kline JA; Department of Emergency Medicine, School of Medicine, Wayne State University, Detroit, MI (J.A.K.)., Klok FA; Department of Medicine-Thrombosis and Hemostasis, Leiden University Medical Center, Netherlands (M.V.H., F.A.K.).; Dutch Thrombosis Network, Leiden, Netherlands (M.V.H., F.A.K.)., Konstantinides SV; Center for Thrombosis and Hemostasis, University Medical Center Mainz, Germany (S.V.K.).; Department of Cardiology, Democritus University of Thrace, Greece (S.V.K.)., Lanno MT; Pulmonary Embolism Response Team Consortium, Nashua, NH (M.T.L., J.L.R.)., Lookstein R; Department of Radiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.L.)., Moriarty JM; Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles (J.M.M.)., Ní Áinle F; University College Dublin School of Medicine, Mater Misericordiae University Hospital, Ireland (F.N.A.).; Division of Hematology, Royal College of Surgeons in Ireland, Dublin (F.N.A.)., Reed JL; Pulmonary Embolism Response Team Consortium, Nashua, NH (M.T.L., J.L.R.)., Rosovsky RP; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (R.P.R.)., Royce SM; US Food and Drug Administration, Silver Spring, MD (S.M.R., E.M.W.)., Secemsky EA; Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA (E.A.S.)., Sharp ASP; Division of Cardiology, University Hospital of Wales and Cardiff University (A.S.P.S.)., Sista AK; Department of Radiology, Weill Cornell Medicine, New York, NY (A.K.S.)., Smith RE; Department of Medicine, University of Pittsburgh Medical Center, PA (R.E.S.)., Wells P; Department of Medicine, Ottawa Hospital, University of Ottawa, Canada (P.W.)., Yang J; Division of Cardiology, Massachusetts General Hospital, Boston (K.R., J.Y.)., Whatley EM; US Food and Drug Administration, Silver Spring, MD (S.M.R., E.M.W.).

Publikováno v: Circulation [Circulation] 2024 Oct; Vol. 150 (14), pp. 1140-1150. Date of Electronic Publication: 2024 Sep 12.

Response to 'Why the lack of enthusiasm for renal denervation?'

Autor: Sharp ASP; School of Medicine, University College Dublin.; Department of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland., Sanderson A; York Health Economics Consortium Ltd, York Science Park, York, UK., Hansell N; York Health Economics Consortium Ltd, York Science Park, York, UK., Reddish K; York Health Economics Consortium Ltd, York Science Park, York, UK., Miller P; York Health Economics Consortium Ltd, York Science Park, York, UK., Moss J; York Health Economics Consortium Ltd, York Science Park, York, UK., Schmieder RE; Department of Nephrology and Hypertension University Hospital Erlangen, Friedrich Alexander University, Erlangen/Nürnberg, Germany., McCool R; York Health Economics Consortium Ltd, York Science Park, York, UK.

Publikováno v: Journal of hypertension [J Hypertens] 2024 Dec 01; Vol. 42 (12), pp. 2215-2217. Date of Electronic Publication: 2024 Oct 31.